Provided by Tiger Trade Technology Pte. Ltd.

Myriad Genetics

4.20
-0.0800-1.87%
Pre-market: 4.17-0.0300-0.71%07:27 EDT
Volume:2.26M
Turnover:9.46M
Market Cap:401.52M
PE:-3.49
High:4.26
Open:4.24
Low:4.05
Close:4.28
52wk High:8.59
52wk Low:2.74
Shares:95.60M
Float Shares:79.40M
Volume Ratio:1.12
T/O Rate:2.85%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.2031
EPS(LYR):-3.9514
ROE:-32.54%
ROA:-8.59%
PB:1.32
PE(LYR):-1.06

Loading ...

Myriad, Sophia advance prostate cancer-specific genomic instability score tech

TIPRANKS
·
Yesterday

Myriad Genetics and Sophia Genetics Announce New Collaboration to Advance Prostate Genomic Instability Score Technology

THOMSON REUTERS
·
Yesterday

Myriad Genetics is Maintained at Buy by Craig-Hallum

Dow Jones
·
Oct 03

Myriad Genetics price target raised to $8 from $4 at Craig-Hallum

TIPRANKS
·
Oct 02

Myriad Genetics EVP Commercial Vishal Sikri Files Initial Beneficial Ownership Statement

Reuters
·
Sep 18

Myriad Genetics Announces Key Commercial Leadership Transition

TIPRANKS
·
Sep 16

Myriad Genetics Names Vishal Sikri EVP, Commercial

Reuters
·
Sep 16

Myriad Genetics Appoints Vishal Sikri Executive Vice President - Commercial

THOMSON REUTERS
·
Sep 16

Myriad Genetics is Maintained at Neutral by UBS

Dow Jones
·
Sep 10

UBS Adjusts Price Target on Myriad Genetics to $3.60 From $6, Keeps Neutral Rating

MT Newswires Live
·
Sep 09

Myriad Genetics (MYGN) Gets a Hold from UBS

TIPRANKS
·
Sep 09

Myriad Genetics Shares Fall After Piper Sandler Downgrade

MT Newswires Live
·
Sep 02

U.S. Stocks on the MOVE-GoPro, TXNM Energy, Emergent BioSolutions

Reuters
·
Sep 01

U.S. Stocks on the MOVE-Robinhood Markets, Park Hotels & Resorts, Capricor Therapeutics

Reuters
·
Sep 01

Myriad Genetics downgraded to Underweight from Overweight at Piper Sandler

TIPRANKS
·
Sep 01

Analyst Cuts Myriad Genetics to Sell, Slashes Price Target to $2 Amid Structural Profitability Concerns

TIPRANKS
·
Sep 01

Myriad Genetics Shares Down 4.3% Premarket After Piper Sandler Cuts to Underweight from Overweight

THOMSON REUTERS
·
Sep 01

Myriad Genetics, Inc. : Piper Sandler Cuts to Underweight from Overweight; Cuts Target Price to $2 from $5.45

THOMSON REUTERS
·
Sep 01

Myriad Genetics to Present at Wells Fargo Healthcare Conference

Reuters
·
Aug 27

Myriad Genetics, Inc. : Jefferies Cuts Target Price to $2.5 from $4

THOMSON REUTERS
·
Aug 21